Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway - Chang, T C; Chiou, W C; Lai, W H; Huang, H C; Huang, Y L; Liu, H K; Liang, Y C; Huang, C (Pharmacol Res, 2021)